Abstract:Hepatitis C virus (HCV) is an important human pathogen that causes chronic liver disease worldwide. It is desirable to develop vaccines to prevent HCV infection, or at least to prevent progression to chronicity. We once constructed an optimized hepatitis C virus core and envelope 2 fusion antigen DNA vaccine, which could induce humoral and cellular immune responses against HCV core and E2 protein in BALB/c mice efficiently. Flt3 (Fms-like tyrosine kinase 3) -ligand has been identified as an important cytokine for the generation of professional antigen-presenting cells, particularly dendritic cells. We reasoned that a DNA vaccine coexpressing the antigen and FL may activate immune responses more effectually. In this study, The influence of FL on this HCV DNA vaccine was evaluated. The cDNA encoding signal peptide and extracellular domain of murine FL was inserted into the plasmid pST-CE2t, and the resulting plasmid pST-CE2t/FL was transfected into COS7 cells. The HCV core and E2 protein were detected by Western blotting, and the soluble murine FL was detected by ELISA. Eight-week-old female BALB/c mice were inoculated intramuscularly with 100 microg pST-CE2t, pST-CE2t/FL or mock vector, respectively, and boosted at the same dosage 3 weeks later. Anti-HCV core and E2 total IgG and isotypes were measured at weeks 1,3,5,7. Splenocyte proliferative response to recombinant HCV core and E2 protrein were detected at week 7. SP2/0 cells expressing HCV core protein were used as target cells for the detection of cytotoxic T lymphocyte (CTL) response. Western blot analysis showed that a protein band with molecular weight about 70 kD from lysate of COS7 cells transfected with plasmid pST-CE2t/FL could be detected by anti-HCV core or E2 monoclonal antibodies, which indicated that pST-CE2t could express glucosylated HCV core and E2 fusion protein. Murine FL could be detected in the culture supernatant of COS7 cells transfected with pST-CE2t/FL. Plasmid pST-CE2t immunized mice developed higher anti-HCV core and E2 IgG seroconversion rates and titers than pST-CE2t/FL group did at different various times, but the IgG2a/IgG1 ratio of anti-HCV E2 protein in pST-CE2t/FL group is much higher than pST-CE2t group. Splenocytes from pST-CE2t or pST-CE2t/FL immunized mice could proliferate with stimulation of HCV core or E2 protein in vitro, although pST-CE2t/FL group showed much stronger response. Splenocytes from mice immunized with pST-CE2t/FL induced 79.03% +/- 9.95% of target cell lysis at the effector/target ratio of 100:1, which was significantly greater than the lysis (62.2% +/- 8.62%) observed in mice immunized with pST-CE2t. Our data demonstrated that the incorporation of FL can preferentially enhance the cellular response to this HCV fusion antigen DNA vaccine. In contrast, HCV specific antibodies were inhibited by FL in vaccinated mice. More and more data supports that recovery from acute HCV infection may depend upon the generation of broad-based cellular immune responses to viral proteins. So, FL may be of potential value as an adjuvant in the development of DNA-based immunization for prophylactic and therapeutic vaccine against HCV infection.

Construction of HCV core and envelope 2 fusion gene DNA vaccine and its immunogenicity in mice

Immune Responses Elicited by Oral DNA Vaccine of Hepatitis C Virus Fusion Antigen in Mice

Construction of Hepatitis C Virus DNA Vaccine and Its Effects in Mice

Dna Immunization with Fusion Genes Encoding Different Regions of Hepatitis C Virus E2 Fused to the Gene for Hepatitis B Surface Antigen Elicits Immune Responses to Both Hcv and Hbv

Immune Responses to DNA Vaccine of Hepatitis C Virus Structural Gene

DNA Immunization with Fusion Genes Containing HCV Core Region and HBV Core Region

[Enhancement of Cellular Immune Response to DNA Vaccine Encoding Hepatitis C Virus Core and Envelope 2 Fusion Antigen by Murine Fms-like Tyrosine Kinase 3 Ligand].

[Immune Responses to Recombinant Expression Plasmid Encoding Hepatitis C Virus Core Antigen].

Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag

Construction and Gene Immunization of Recombinant Expression Plasmid of Hepatitis C Virus Core Gene

Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.

Construction and Characterization of an HCV-derived Multi-Epitope Peptide Antigen Containing B-cell HVR1 Mimotopes and T-cell Conserved Epitopes

Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model

Expression and Characterization of Hepatitis C Virus Core Protein Fused to Hepatitis B Virus Core Antigen

Enhancement of Immune Responses of Hepatitis B Virus Core Dna Vaccine by A Signal Peptide and A Universal Helper T Lymphocyte Epitope

Immunogenicity study of a Novel DNA-Based HCV vaccine candidate

A Candidate DNA Vaccine Elicits HCV Specific Humoral and Cellular Immune Responses.

Hepatitis C Virus E2 Protein Encapsulation into Poly D, L-Lactic-co-glycolide Microspheres Could Induce Mice Cytotoxic T-cell Response.

Strong and Durable Cellular Immune Responses in Mice Induced by Hepatitis B Virus Envelope and Core Fusion Gene Dna Vaccine

Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization.